Evotec SE (OTCMKTS:EVTCY – Get Free Report) crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $3.69 and traded as low as $3.59. Evotec shares last traded at $3.60, with a volume of 494,077 shares.
Evotec Trading Up 10.1 %
The firm has a market cap of $1.19 billion, a price-to-earnings ratio of 8.78 and a beta of 0.98. The business has a 50 day moving average of $3.69 and a 200 day moving average of $4.21. The company has a quick ratio of 2.50, a current ratio of 2.57 and a debt-to-equity ratio of 0.53.
About Evotec
Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.
Featured Articles
- Five stocks we like better than Evotec
- How to Capture the Benefits of Dividend Increases
- AST SpaceMobile: 5 Reasons to Buy This Tiny Trailblazer Stock
- Investing in Travel Stocks Benefits
- Why Call Option Traders Are Targeting This Dividend ETF Now
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Is Alphabet Misunderstood? Here’s Why the Bulls Are Buying
Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.
